Trump warns pharma companies to cut prices or be punished
WASHINGTON : US President Donald Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world.
In letters to 17 drug companies published on his Platform Truth Social, Trump said he wants the firms to work with his administration to institute a series of changes within 60 days.
'If you refuse to step up we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices,' Trump wrote without specifying what the consequences would entail.
Trump is following up an on executive order he signed in May to address US drug prices that are among the highest in the world – more than three times what people in similarly developed countries pay, the White House said Thursday.
In the letters Trump said the response he has received so far to his order from companies have been 'more of the same: shifting blame' and policy changes that would in fact benefit the industry, not consumers.
Key to the Trump plan is a 'Most Favored Nation' policy that pins the cost of drugs sold in the US to the lowest price paid by other countries for the same drug.
Trump said Thursday he wants the companies to extend this pricing policy to medications used by older people under the government-backed health program Medicaid.
He also wants this status to apply to new drugs, Trump said in the letters.
'Americans are demanding lower drug prices and they need them today,' Trump wrote.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Free Malaysia Today
16 minutes ago
- Free Malaysia Today
US axes mRNA vaccine contracts, casting safety doubts
The affected projects, worth nearly US$500 million, included Moderna's bird flu vaccine and cancelled bids from Pfizer and Sanofi. (AP pic) WASHINGTON : President Donald Trump's administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology credited with helping end the Covid pandemic and saving millions of lives. The announcement, made by health secretary Robert F. Kennedy Jr, marks his latest effort to weave vaccine skepticism into the core of US government policy. 'We reviewed the science, listened to the experts, and acted,' Kennedy said in a statement. The health department's Biomedical Advanced Research and Development Authority (BARDA) is 'terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu,' he added. 'We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.' The changes affect Moderna's mRNA bird flu vaccine – a move the company itself disclosed in May – as well as numerous other programmes, including 'rejection or cancellation of multiple pre-award solicitations' from pharmaceutical giants Pfizer and Sanofi. In total, the affected projects are worth 'nearly US$500 million,' the Department of Health and Human Services (HHS) said. Certain late-stage projects were excluded from the move 'to preserve prior taxpayer investment.' 'Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them,' Secretary Kennedy said. 'That's why we're moving beyond the limitations of mRNA and investing in better solutions.' Since taking office, Kennedy, who spent two decades sowing misinformation around immunisation, has overseen a major overhaul of US health policy – firing, for example, a panel of vaccine experts that advise the government and replacing them with his own appointees. In its first meeting, the new panel promptly voted to ban a longstanding vaccine preservative targeted by the anti-vaccine movement, despite its strong safety record. He has also ordered a sweeping new study on the long-debunked link between vaccines and autism. Unlike traditional vaccines, which often use weakened or inactivated forms of the target virus or bacteria, mRNA shots deliver genetic instructions into the host's cells, prompting them to produce a harmless decoy of the pathogen and train the immune system to fight the real thing. Though in development for decades, mRNA vaccines were propelled from lab benches to widespread use through President Trump's Operation Warp Speed – a public-private partnership led by BARDA that poured billions into companies to accelerate development. The technology's pioneers, Katalin Kariko and Drew Weissman, were awarded the 2023 Nobel Prize in Medicine for their work contributing 'to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times.'
New Straits Times
an hour ago
- New Straits Times
Oil prices rebound from 5-week low on Trump threats on Russian crude buyers
TOKYO: Oil prices climbed on Wednesday, rebounding from a five-week low in the previous day, on concerns of supply disruptions after US President Donald Trump's threats of tariffs on India over its Russian crude purchases. Brent crude futures rose 29 cents, or 0.4 per cent, to US$67.93 a barrel by 0119 GMT while US West Texas Intermediate crude was at US$65.44 a barrel, up 28 cents, or 0.4 per cent. Both contracts fell by more than US$1 on Tuesday to settle at their lowest in five weeks, marking a fourth session of losses, on oversupply concerns from OPEC+'s planned September output hike. "Investors are assessing whether India will reduce its Russian crude purchases in response to Trump's threats, which could tighten supply, but it remains to be seen if that will actually happen," said Yuki Takashima, economist at Nomura Securities. "If India's imports remain steady, WTI is likely to stay within the US$60-70 range for the rest of the month," he said. The Organization of the Petroleum Exporting Countries and its allies, together known as OPEC+, agreed on Sunday to raise oil production by 547,000 barrels per day for September, a move that will end its most recent output cut earlier than planned. The OPEC+ pumps about half of the world's oil and had been curtailing production for several years to support the market, but the group introduced a series of accelerated output hikes this year to regain market share. At the same time, US demands for India to stop buying Russian oil as Washington seeks ways to push Moscow for a peace deal with Ukraine could upset supply flows as Indian refiners seek alternatives and Russian crude is redirected to other buyers. Trump on Tuesday again threatened higher tariffs on Indian goods over the country's Russian oil purchases over the next 24 hours. Trump also said declining energy prices could pressure Russian President Vladimir Putin to halt the war in Ukraine. New Delhi called Trump's threat "unjustified" and vowed to protect its economic interests, deepening a trade rift between the two countries. Nomura's Takashima also pointed to industry data showing crude inventories in the US, the world's biggest oil consumer, as supportive for the oil market. US crude inventories fell by 4.2 million barrels last week, sources citing American Petroleum Institute figures said on Tuesday. That compares with a Reuters poll estimate of a 600,000 barrels draw for the week to August 1. The US Energy Information Administration is due to release its weekly inventory data on Wednesday.
Malay Mail
an hour ago
- Malay Mail
Facing 20 years' jail, Diddy asks Trump for pardon, but US president says ‘he was very hostile' during campaigning
WASHINGTON, Aug 6 — Music mogul Sean 'Diddy' Combs, who is to be sentenced in October for his conviction on prostitution-related charges, is seeking a pardon from President Donald Trump, one of his lawyers said Tuesday. 'It's my understanding that we've reached out and had conversations in reference to a pardon,' Nicole Westmoreland told CNN in an interview. Trump has indicated, however, that he is unlikely to grant a pardon to the 55-year-old Combs. 'I was very friendly with him. I got along with him great and he seemed like a nice guy,' Trump said in an interview on Friday with Newsmax. 'I didn't know him well, but when I ran for office, he was very hostile.' Asked if that meant he was not inclined to pardon Combs, Trump said: 'I would say so, yeah.' A New York jury found Combs guilty last month of two counts of transportation to engage in prostitution, each of which carries a maximum sentence of 10 years in prison. He was acquitted of racketeering and sex trafficking charges after a marathon trial in which he was accused of harrowing abuse. Sentencing has been set for October 3. — AFP
